European Archives - Page 7 of 1199 - European Medical Journal

Comparative Study Questions Cardiovascular Safety of Glipizide

Discover how new research found that glipizide carries higher cardiovascular risk than DPP4 inhibitors in Type 2 diabetes treatment.

Modifiable Risk Factors Behind Majority of Liver Cancers

At least 60% of liver cancer diagnoses are linked to modifiable risk factors and could be prevented through global interventions

Pharmacist-Led Approach Improves Allergic Rhinitis Outcomes

The study found that patients receiving the AR-PRISE intervention experienced significant improvements in symptom control, particularly over the longer term.

I-O for Resectable NSCLC

In this symposium, Frank Griesinger, Cecilia Pompili, and Jesme Fox discussed the latest evidence for neoadjuvant and…

New Heights in Paediatric Cholestasis

If you couldn’t attend the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) 2025 Annual Meeting in…

Review of HLTH Europe 2025

EUROPE’s number one healthcare innovation event, HLTH Europe, was held this year in Amsterdam, the Netherlands, from the 16th–19th June…

EMJ Innovations 9 [Supplement 2] 2025

The HLTH Europe Supplement Journal is here! Access expert insights from the 2025 event, including an exclusive interview with the Head of…

HLTH Europe 2025: Where Vision Meets Action

IT IS with genuine pleasure and a full heart that I reflect on HLTH Europe 2025, an event that did more than bring together healthcare…

Broadening Horizons in Health Innovation: Insights from HLTH Europe 2025

NOW IN its seventh year, HLTH has evolved into a global bellwether for innovation in healthcare. HLTH Europe 2025 convened over 12,000…

Lower eGDR Linked to Higher Gallstone Risk

This study focused on eGDR, a widely accessible proxy for insulin sensitivity derived from waist circumference, hypertension status, and HbA1c levels.